Champions Oncolog (CSBR)
6.64 x 1 9.50 x 1
Pre-market by (Cboe BZX)
7.31 -0.59 (-7.47%) 04/28/25 [NASDAQ]
6.64 x 1 9.50 x 1
Pre-market 7.31 unch (unch) 16:00 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | CSBR | SLN | OPTN | ||
| Company | Champions Oncolog | Silence Therapeutics Plc ADR | Optinose Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 7.98 | 3.36 | 9.29 | ||
| High | 8.27 | 3.51 | 9.35 | ||
| Low | 7.21 | 3.08 | 9.25 | ||
| Last | 7.31 | 3.50 | 9.34 | ||
| Change | -0.59 | +0.14 | +0.06 | ||
| % Change | -7.47% | +4.17% | +0.65% | ||
| Volume | 83,300 | 286,000 | 25,400 | ||
| 20-Day Average Volume | 37,445 | 316,070 | 102,855 | ||
| Previous Close | 7.90 | 3.36 | 9.28 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.00 | 2.83 | 9.15 | ||
| 20-Day Raw Stochastic | 13.39% | 90.19% | 98.33% | ||
| 20-Day Relative Strength | 40.45% | 50.01% | 74.02% | ||
| Weighted Alpha | +19.68 | -74.87 | -36.14 | ||
| Today's Opinion | 8% Sell | 88% Sell | 24% Buy | ||
| Previous Opinion | 8% Buy | 88% Sell | 24% Buy | ||
| Last Month's Opinion | 40% Buy | 100% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.70% since 04/21/25 | +9.37% since 04/21/25 | +1.97% since 04/21/25 | ||
| Low | 7.21 on 04/28/25 | 2.96 on 04/22/25 | 9.14 on 04/22/25 | ||
| High | 8.27 on 04/28/25 | 3.67 on 04/25/25 | 9.35 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | -19.76% since 03/28/25 | +1.74% since 03/28/25 | +2.08% since 03/28/25 | ||
| Low | 7.01 on 04/07/25 | 1.97 on 04/10/25 | 8.75 on 04/09/25 | ||
| High | 9.25 on 03/31/25 | 3.67 on 04/25/25 | 9.35 on 04/28/25 | ||
| 3-Month | |||||
| %Chg | -31.87% since 01/28/25 | -34.46% since 01/28/25 | +51.87% since 01/28/25 | ||
| Low | 7.01 on 04/07/25 | 1.97 on 04/10/25 | 5.10 on 03/04/25 | ||
| High | 11.98 on 02/10/25 | 6.29 on 02/06/25 | 9.60 on 03/20/25 | ||
| 6-Month | |||||
| %Chg | +83.67% since 10/28/24 | -80.63% since 10/28/24 | -20.53% since 10/28/24 | ||
| Low | 3.75 on 10/31/24 | 1.97 on 04/10/25 | 4.82 on 11/20/24 | ||
| High | 11.99 on 01/28/25 | 18.29 on 11/04/24 | 12.00 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 101,075 | 104,755 | 94,586 | ||
| Shares Outstanding, K | 13,827 | 29,930 | 10,127 | ||
| Annual Sales | 50,160,000 | 43,260,000 | 78,230,000 | ||
| Annual Net Income | -7,280,000 | -45,310,000 | -21,540,000 | ||
| Last Quarter Sales | 17,040,000 | 25,290,000 | 22,420,000 | ||
| Last Quarter Net Income | 4,500,000 | 11,840,000 | -360,000 | ||
| 60-Month Beta | 0.46 | 1.25 | -0.87 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.31 on 03/11/25 | 0.27 on 02/27/25 | -0.03 on 03/26/25 | ||
| Latest Earnings Date | 03/11/25 | 05/15/25 | 05/13/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 17.95 | 0.00 | 0.00 | ||